Bloomberg reports that Denmark-based vaginal mesh manufacturer Coloplast’s stock dropped the most in almost four years over concerns about lawsuits that patients injured by the implants have filed.
The story says a joint status conference is scheduled for lawsuits filed against vaginal mesh manufacturers including Coloplast, American Medical Systems Holdings Inc., CR Bard Inc. and Boston Scientific Corp.
The mesh implants are supposed to treat urinary incontinence and pelvic organ prolapse, which ...
continue reading...
A column by local physician Christie Iverson, MD, in the Bismarck Tribune out of North Dakota describes pelvic organ prolapse. Iverson writes that the condition is basically what happens when a woman’s pelvic floor weakens and the vaginal walls protrude, or a weakened uterus descends into the vaginal canal.
A judge recently ordered Johnson & Johnson’s Ethicon division to pay Irish health care products manufacturer Covidien $176.5 million in damages over a patent dispute, Bloomberg reports.
Urinary incontinence can have a number of causes, according to the Mayo Clinic. They run the gamut from temporary causes, such as medication or overhydration; to relatively minor conditions such as urinary tract infection; to relatively serious causes such as bladder cancer.
CTV Network out of Canada reports on a Manitoba woman who is staging a protest about the vaginal mesh device she had implanted during a hysterectomy in January, 2012.
Members of a New Jersey jury that awarded a total of $11.1 million to a woman who received a vaginal mesh implant manufactured by Johnson & Johnson’s Ethicon subsidiary did not find a design defect, according to a lawyer for the plaintiff. But they did rule that the company failed to warn the plaintiff’s doctor of the hazards, and that patient brochures fraudulently misrepresented the procedure.
